# Dren Bio funding rounds and investors

As of 29 Oct 2026, Dren Bio has raised $350M across 1 verified round on record, plus 1 round still being checked; latest: $350 million funding round led by Juvia Group and Lightspeed, announced 28 Oct 2026.

A privately held, clinical-stage biotechnology company developing first-in-class antibody therapeutics for cancer, autoimmune, and other serious diseases

Website: https://drenbio.com  
Headquarters: Foster City, CA  
Page: https://fireround.dev/companies/dren-bio

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-28 | Funding round | $350 million | Juvia Group, Lightspeed | 8VC, Aisling Capital, ArrowMark Partners, BVF Partners, Cormorant Asset Management, General Catalyst, HBM Healthcare Investments, Mirae Asset Capital Life Science, Mission BioCapital, OrbiMed, SR One, Taiho Ventures | [businesswire.com](https://www.businesswire.com/news/home/20261028459890/en/Dren-Bio-Announces-%24350-Million-Financing-to-Advance-Dibotatug-Toward-Commercialization-and-Accelerate-Development-of-Its-Broader-Pipeline), [biospace.com](https://www.biospace.com/press-releases/dren-bio-announces-350-million-financing-to-advance-dibotatug-toward-commercialization-and-accelerate-development-of-its-broader-pipeline), [ca.finance.yahoo.com](https://finance.yahoo.com/news/dren-bio-announces-350-million-113000763.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.